Form 4 for CRL Charles River Laboratories
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-02 · accession 0001127602-24-014153 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-03 | 2024-05-02 | CRL | Pease Flavia | CFO, Corp. Executive VP | F - Tax | $232.69 | -893 | 8,007 | -10% | -$207.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | F | D | 893 | $232.69 | 8,007 | D | — | — |